- Neusoft Corporation ("Neusoft", SSE:600718) announced today that it has signed a Term Sheet with Philips on the ...
- Masimo (NASDAQ: MASI) returns to Arab Health Jan. 28-31, the world's longest running healthcare exhibition and ...
- Bausch + Lomb, the global eye health company, announced today that it has completed its acquisition of Technolas ...
- ChanTest announced today the capability to perform a bioassay in conformance with current Good Manufacturing ...
- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- March 2011 Data Confirm Strong Treatment Effect of ...
- - elure Advanced Skin Lightening Products captures the ...
- - First Randomized Controlled Trial to Show That Basal Plus ...
- Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...
-FDA allows use of investigational new drug for life-threatening indications Edison ...
-Designation covers inherited respiratory chain diseases of the mitochondria Edison Pharmaceuticals, ...
- - NOT INTENDED FOR US MEDIA - Ingenol Mebutate is an ...
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
Badan Obat dan Makanan Thailand (FDA) telah memerintahkan pemeriksaan acak bagi segala makanan dan meminta importir ...
- The New Infini(TM) System Provides Healthcare Systems with an Alternative System for ...